Cisplatin and Cetirizine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cisplatin (cisplatin) and Cetirizine hydrochloride (cetirizine hydrochloride). Common drug interactions include diarrhoea among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Cisplatin and Cetirizine hydrochloride. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Cetirizine hydrochloride?

Cetirizine hydrochloride has active ingredients of cetirizine hydrochloride. It is often used in allergies. eHealthMe is studying from 34,908 Cetirizine hydrochloride users. Check the latest studies of Cetirizine hydrochloride.



On Jul, 08, 2026

26 people who take Cisplatin and Cetirizine hydrochloride together, and have interactions are studied.

Cisplatin and Cetirizine hydrochloride drug interactions.

What are the common drug interactions of Cisplatin and Cetirizine Hydrochloride, by gender? *:

female:

  1. Diarrhoea
  2. Abdominal pain
  3. Addison's disease (addison's disease, a hormonal disorder disease)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  6. Erythema (redness of the skin)
  7. Headache (pain in head)
  8. Nausea (feeling of having an urge to vomit)
  9. Neoplasm malignant (cancer tumour)
  10. Pruritus (severe itching of the skin)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Platelet count decreased
  3. Abdominal pain upper
  4. Anaemia (lack of blood)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Neoplasm progression (growth of tumour)
  7. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  8. Myelosuppression (a decrease in the production of blood cells)
  9. Abdominal distension
  10. Back pain

What are the common drug interactions of Cisplatin and Cetirizine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal distension
  2. Abdominal pain upper
  3. Back pain
  4. Chills (felling of cold)
  5. Cough
  6. Decreased appetite
  7. Dizziness
  8. Dyspepsia (indigestion)
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

40-49:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Platelet count decreased
  3. Addison's disease (addison's disease, a hormonal disorder disease)
  4. Renal impairment (severely reduced kidney function)

50-59:

  1. Anaemia (lack of blood)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  4. Myelosuppression (a decrease in the production of blood cells)
  5. Diarrhoea
  6. Erythema (redness of the skin)
  7. Haemoglobin decreased
  8. Pruritus (severe itching of the skin)
  9. Renal failure (kidney dysfunction)

60+:

  1. Cholecystitis acute (rapid infection of gallbladder)
  2. Conjunctivitis (pink eye)
  3. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  4. Headache (pain in head)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Intestinal obstruction
  7. Neoplasm progression (growth of tumour)
  8. Renal failure (kidney dysfunction)
  9. Septic shock (shock due to blood infection)
  10. Tumour thrombosis (blood clot in tumour)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 10 people, 38.46%
  2. Rashes (redness): 7 people, 26.92%
  3. Thrombocytopenia (decrease of platelets in blood): 4 people, 15.38%
  4. Hypersensitivity: 4 people, 15.38%
  5. White Blood Cell Count Decreased: 3 people, 11.54%
  6. Toothaches (tooth pain): 3 people, 11.54%
  7. Oesophageal Carcinoma (cancer tumour of oesophagus): 3 people, 11.54%
  8. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 11.54%
  9. Nausea (feeling of having an urge to vomit): 3 people, 11.54%
  10. Hypoproteinaemia (too little prolactin circulating in the blood): 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and Cetirizine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cisplatin and Cetirizine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cetirizine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cisplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cetirizine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cisplatin and cetirizine hydrochloride (the active ingredients of Cisplatin and Cetirizine hydrochloride, respectively), and Cisplatin and Cetirizine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: